Trials / Sponsors / RTOG Foundation, Inc.
RTOG Foundation, Inc.
Academic / Other · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Me Intracranial Meningioma | Phase 2 | 2025-12-24 |
| Active Not Recruiting | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Prostate Cancer | Phase 2 | 2019-04-15 |
| Active Not Recruiting | SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | 2018-11-14 |
| Terminated | Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma Glioblastoma, Glioma, Gliosarcoma | Phase 2 | 2017-05-09 |
| Terminated | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC Non-Small Cell Lung Cancer | Phase 3 | 2016-10-17 |
| Completed | Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionall Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 1 | 2016-06-01 |